Skip to content

Dissecting Down Syndrome

Dissecting Down Syndrome - Dissecting Down Syndrome

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON42548
Enrollment
40
Registered
2015-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down syndrome Trisomy 21

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Patients: - Individuals with Down syndrome caused by an extra, not translocated copy of chromosome 21 - Age 0 - 1 yr Controls - Individuals without Down syndrome and a non-hereditary disorder fo which blood sampling is needed - Age 01- yr

Exclusion criteria

Exclusion criteria: Individual with Down syndrome with a major malformation.

Design outcomes

Primary

MeasureTime frame
Significant differences in DNA-methylation- and genetranscription profiles between controls and DS individuals.

Secondary

MeasureTime frame
None.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)